Will US Supreme Court Come To Teva’s Rescue On ‘Skinny Label’ Battle?
Israeli Firm Petitions For Certiorari Review Of Labelling Carve-Outs Litigation With GSK
Teva has made good on its stated intention to bring its long-running US legal battle with GSK over “skinny-label” generics to the Supreme Court. In a detailed certiorari petition, the firm sets out its arguments for why the matter warrants review.
